Inventor · disambiguated record
Charles Rodney Greenaway Evans
Also filed as: EVANS CHARLES · EVANS CHARLES RODNEY GREENAWAY
10 granted patents·11 pending applications·6 citations·filing 2016–2025
81Inventor score
Files withDERMBIONT INC3PELLEPHARM INC3TIMBER PHARMACEUTICALS LLC3BENEVOLENTAI BIO LTD2LIPIDIO PHARMACEUTICALS INC2
Top patents by PatentIndex Score
21 records- 0183US10695344B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2019·Granted Jun 30, 2020·2 cites·20 claims
- 0280US12290506B2Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2024·Granted May 6, 2025·0 cites·21 claims
- 0379US12419896B2Compositions and dosage forms for oral deliveryRHODES TECH·Filed 2024·Granted Sep 23, 2025·0 cites·19 claims
- 0478US10369147B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2016·Granted Aug 6, 2019·3 cites·10 claims
- 0574US2025367097A1Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2023·Application pending·0 cites
- 0673US2025302810A1Formulations of pyrrolopyridine-aniline compoundsNFLECTION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0768US10933018B2Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2016·Granted Mar 2, 2021·1 cites·12 claims
- 0867US12011430B2Compositions and dosage forms for oral deliveryRHODES TECH·Filed 2019·Granted Jun 18, 2024·0 cites·14 claims
- 0967US2022362148A1Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1066US12310950B2Formulations of pyrrolopyridine-aniline compoundsNFLECTION THERAPEUTICS INC·Filed 2022·Granted May 27, 2025·0 cites·25 claims
- 1165US11413283B2Topical formulations for delivery of hedgehog inhibitor compounds and use thereofPELLEPHARM INC·Filed 2020·Granted Aug 16, 2022·0 cites·21 claims
- 1265US2024307388A1Formulations for substituted 3-pyrrolidines, compositions containing, and uses of sameLIPIDIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1364US2025228822A1Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2025·Application pending·0 cites
- 1463US11471408B2Isotretinoin formulations and uses and methods thereofTIMBER PHARMACEUTICALS LLC·Filed 2020·Granted Oct 18, 2022·0 cites·17 claims
- 1559US2023172937A1Topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseasesINCYTE CORP·Filed 2022·Application pending·0 cites
- 1651US2020038392A1Topical compositions and methods of preparation and useALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1750US11865113B2Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)LIPIDIO PHARMACEUTICALS INC·Filed 2017·Granted Jan 9, 2024·0 cites·9 claims
- 1848US2020390689A1Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereofDermavant Sciences GmbH·Filed 2019·Application pending·0 cites
- 1944US2023112039A1Pharmaceutical compositions and their usesBENEVOLENTAI BIO LTD·Filed 2021·Application pending·0 cites
- 2042US2023149398A1Topical pharmaceutical compositions comprising imidazo[1,2-b]pyridazine compoundsBENEVOLENTAI BIO LTD·Filed 2021·Application pending·0 cites
- 2142US2018325839A1Transdermal patchesBUZZZ PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →